ATE332919T1 - Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen - Google Patents

Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen

Info

Publication number
ATE332919T1
ATE332919T1 AT98946921T AT98946921T ATE332919T1 AT E332919 T1 ATE332919 T1 AT E332919T1 AT 98946921 T AT98946921 T AT 98946921T AT 98946921 T AT98946921 T AT 98946921T AT E332919 T1 ATE332919 T1 AT E332919T1
Authority
AT
Austria
Prior art keywords
phosphoserine
inhibitors
phosphothreonen
specific
specific isomerases
Prior art date
Application number
AT98946921T
Other languages
English (en)
Inventor
Kun Ping Lu
Lewis C Cantley
Michael Yaffee
Gunter Fischer
Original Assignee
Beth Israel Hospital
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital, Max Planck Gesellschaft filed Critical Beth Israel Hospital
Application granted granted Critical
Publication of ATE332919T1 publication Critical patent/ATE332919T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98946921T 1997-09-08 1998-09-04 Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen ATE332919T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5816497P 1997-09-08 1997-09-08
US08/988,842 US6462173B1 (en) 1997-09-08 1997-12-11 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases

Publications (1)

Publication Number Publication Date
ATE332919T1 true ATE332919T1 (de) 2006-08-15

Family

ID=26737312

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946921T ATE332919T1 (de) 1997-09-08 1998-09-04 Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen

Country Status (8)

Country Link
US (2) US6462173B1 (de)
EP (1) EP1012178B1 (de)
JP (1) JP2001515917A (de)
AT (1) ATE332919T1 (de)
AU (1) AU751271B2 (de)
CA (1) CA2303462A1 (de)
DE (1) DE69835215T2 (de)
WO (1) WO1999012962A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972697A (en) 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins
US7125677B2 (en) 1995-11-13 2006-10-24 The Salk Institute For Biological Studies NIMA interacting proteins
US20010016346A1 (en) * 1998-06-09 2001-08-23 Joseph P. Noel Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore
US6495376B1 (en) * 1999-02-18 2002-12-17 Beth Israel Deaconess Medical Center Methods and compositions for regulating protein-protein interactions
US20020025521A1 (en) 1999-11-29 2002-02-28 Lu Kun Ping Pin1 as a marker for abnormal cell growth
EP1446044A4 (de) * 2001-02-09 2007-08-08 Pintex Pharmaceuticals Inc Pin1 als marker für prostatakrebs
ATE421525T1 (de) * 2001-08-20 2009-02-15 Max Planck Gesellschaft Katalyse der cis-trans isomerisierung von sekundären-amid peptidverbindungen
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
WO2003074001A2 (en) * 2002-03-01 2003-09-12 Pintex Pharmaceuticals, Inc. Methods for designing specific inhibitors for pin1 proline isomerase and pin1-related molecules
AU2003258982A1 (en) * 2002-06-28 2004-01-19 Pintex Pharmaceuticals, Inc. Methods of inhibiting pin1-associated states using a fredericamycin a compound
WO2004016751A2 (en) * 2002-08-15 2004-02-26 Beth Israel Deaconess Medical Center Methods of treating neurodegenerative diseases
US20040176277A1 (en) * 2003-03-03 2004-09-09 Pintex Pharmaceuticals, Inc. Methods of treating Pin1 associated disorders
US20080058276A1 (en) * 2006-01-13 2008-03-06 Cornell Research Foundation, Inc. Alzheimer's disease therapeutics based on pin-1 catalyzed conformational changes in phosphorylated amyloid precursor protein
US8771693B2 (en) * 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2012125724A1 (en) 2011-03-14 2012-09-20 Beth Israel Deaconess Medical Center Methods and compositions for the treatment of proliferative disorders
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
US9439884B2 (en) 2011-05-26 2016-09-13 Beth Israel Deaconess Medical Center, Inc. Methods for the treatment of immune disorders
US9730941B2 (en) 2012-06-07 2017-08-15 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the inhibition of Pin1
JP6448614B2 (ja) 2013-03-15 2019-01-09 ベス イスラエル デアコネス メディカル センター インコーポレイテッド コンフォメーション特異的抗体の発生および使用のための方法および組成物
US10351914B2 (en) 2014-07-17 2019-07-16 Beth Israel Deaconess Medical Center, Inc. Biomarkers for Pin1-associated disorders
WO2016011268A1 (en) 2014-07-17 2016-01-21 Beth Israel Deaconess Medical Center, Inc. Atra for modulating pin1 activity and stability
US10548864B2 (en) 2015-03-12 2020-02-04 Beth Israel Deaconess Medical Center, Inc. Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444682A (en) * 1982-11-04 1984-04-24 The Salk Institute For Biological Studies Method of sulfation
US4490364A (en) * 1983-05-20 1984-12-25 The Salk Institute For Biological Studies CCK Agonists II
GB2145084B (en) 1983-08-18 1987-01-28 Ss Pharmaceutical Co Fredericamycin derivatives
US4612132A (en) 1984-07-20 1986-09-16 Chevron Research Company Modified succinimides
US5013722A (en) * 1986-06-06 1991-05-07 Hoffmann-Laroche Inc. Cholecystokinin analogs for controlling appetite
US4673678A (en) 1986-07-25 1987-06-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble derivatives of fredericamycin A
JPH03146477A (ja) * 1989-10-31 1991-06-21 Asahi Glass Co Ltd セラミックス接着用組成物およびセラミックスの接着方法
US5733734A (en) * 1991-08-14 1998-03-31 The Trustees Of The University Of Pennsylvania Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
US5166208A (en) 1991-10-09 1992-11-24 Boston College Fredericamycin A derivatives
US5643873A (en) 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5532167A (en) 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases
US5654276A (en) 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5972697A (en) 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins

Also Published As

Publication number Publication date
WO1999012962A8 (en) 1999-07-01
WO1999012962A1 (en) 1999-03-18
EP1012178B1 (de) 2006-07-12
DE69835215D1 (de) 2006-08-24
JP2001515917A (ja) 2001-09-25
US6462173B1 (en) 2002-10-08
AU2703299A (en) 1999-05-24
CA2303462A1 (en) 1999-03-18
EP1012178A1 (de) 2000-06-28
DE69835215T2 (de) 2007-05-31
AU751271B2 (en) 2002-08-08
US20030109423A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
ATE332919T1 (de) Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen
DE60041505D1 (de) Inzektizide proteinen von bacillus thuringiensis
FI962315A (fi) Entsyymi-inhibiittorit
DE69620161D1 (de) Thrombininhibitoren
FI973360A0 (fi) Uusia dipeptidisiä amidiineja trombiininestäjiksi
FI973282A0 (fi) Trombiinin inhibiittoreita
EA199900162A1 (ru) Ингибиторы клеточной адгезии
DE19680255T1 (de) Inhibitoren der Enzymaktivität von Rotamase
ATE214693T1 (de) Aminoguanidine und alkoxyguanidine als protease- hemmer
DE69528528D1 (de) Thrombin-inhibitoren
ATE239755T1 (de) Thrombin inhibitoren
DE69804857T2 (de) Integritätsprüfung von elektroden
DE69831777D1 (de) Framework zur finanziellen Integration von Geschäftsapplikationen
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
NO996578D0 (no) Urokinase-inhibitorer
TR199802240T2 (de)
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
ES2191830T3 (es) Inhibidores de trombina.
ATE268781T1 (de) Thrombininhibitoren
PT927183E (pt) Inibidores espirociclicos de metaloproteases
EE9800044A (et) Prolüülendopeptidaasi inhibiitorid
DE69815278D1 (de) In-Line Verarbeitung von flachen Gegenständen
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
NO20011901L (no) Antikonvulsive derivater nyttige ved behandling av alkoholavhengighet og -misbruk
DE69731664D1 (de) Thrombininhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties